glp-1 drugs pharmaceutical companies news 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP1 agonists set to become

The American Autoimmune Related Diseases Association (AARDA) estimates that about 20 million Americans have one or more forms of peripheral neuropathy

(CALC), announced the discontinuation of its Phase 2 KOURAGE clinical trial that evaluates Auxora in patients with Stage 2 or Stage 3 acute kidney injury with associated acute hypoxemic respiratory failure, following a recommendation from the Independent Data Monitoring Committee

Murugan et al., 2023)

However, medical articles report that some of us can have less naturally occurring glutathione in our body than others

I think AI is going to lead to a rise in people wanting more control and autonomy over their bodies, because there is a rising dissatisfaction or dissonance with medical science after Covid-19